Bio Therapeutic Drugs Company Investment Opportunity in Thiruvananthapuram, India

- During the COVID-19 period, our company supplied hand sanitizers to various organizations and institutions, catering to both B2B and B2C customers.
- Currently, our primary focus is on product formulation and development, where we collaborate with multiple researchers and organizations through outsourcing projects and partnerships.
- In addition, we provide training programs and academic project opportunities for biotechnology and life science students, which has become one of our strong service offerings.
- These programs are widely utilized by students, researchers, and early-stage professionals to gain hands-on laboratory skills and practical exposure in biotechnology research.
- We also collaborate with multiple researchers and organizations through outsourcing works and partnerships. Tangible assets:
- Purchased land for company operations and future expansion.
- Laboratory instruments: Several instruments and equipment for biotechnology research, product formulation, and training activities.
The total value of the land and lab equipment is about INR 1.5 crore.
Intangible assets:
- Business relationships: Established collaborations with researchers, universities, and organizations.
- Brand recognition: Reputation built through COVID-19 supply chain contributions and recognized by awards (Mockingjay Award and IVAEX Women’s Day Award).
- Knowledge assets: Expertise in biotechnology product formulation, R&D outsourcing, and training programs. Our facility is located in a rental property in Trivandrum with two floors, designed to support both research and training activities.
The premises include:
- Specialized laboratories – Dedicated labs for Cell Culture, Molecular Biology, Microbiology, and Biochemistry, equipped with essential instruments for research and product development.
- Student training areas – Classrooms and hands-on training spaces to conduct academic projects, workshops, and skill development programs for biotechnology and life science students.
- Built-up area – 2,800 sq. ft. spread across two floors with sufficient workspace for R&D, collaborative projects, and training sessions.
- The facility is well-structured to handle outsourcing works, product formulation, and student training programs simultaneously. Current funding: The business is primarily self-funded by the company. We have also received several government grants that supported our research and product development activities. In addition, we generate revenue through outsourcing works, training programs, and product sales which help sustain operations.
Debts/loans: The company currently has no outstanding debts or loans.
Shareholding structure: 100% ownership lies with the founders of the company. 75% is with one shareholder while the remaining 25% is split amongst 3 shareholders.